In the last trading session, 6.26 million Abbvie Inc (NYSE:ABBV) shares changed hands as the company’s beta touched 0.62. With the company’s per share price at $199.35 changed hands at $2.93 or 1.49% during last session, the market valuation stood at $352.12B. ABBV’s last price was a discount, traded about -0.3% off its 52-week high of $199.95. The share price had its 52-week low at $135.85, which suggests the last value was 31.85% up since then. When we look at Abbvie Inc’s average trading volume, we note the 10-day average is 4.4 million shares, with the 3-month average coming to 5.21 million.
Analysts gave the Abbvie Inc (ABBV) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.77. If we narrow down to specifics, the data shows that 0 out of 27 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 7 recommended ABBV as a Hold, 20 felt it is a Buy and 0 rated the stock as Underweight. Abbvie Inc’s EPS for the current quarter is expected to be 2.95.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Abbvie Inc (NYSE:ABBV) trade information
Instantly ABBV was in green as seen at the end of in last trading. With action 0.84%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 28.64%, with the 5-day performance at 0.84% in the green. However, in the 30-day time frame, Abbvie Inc (NYSE:ABBV) is 4.96% up. Looking at the short shares, we see there were 20.19 million shares sold at short interest cover period of 3.81 days.
The consensus price target for the stock as assigned by Wall Street analysts is 168, meaning bulls need a downside of -18.66% from its current market value. According to analyst projections, ABBV’s forecast low is 127 with 214 as the target high. To hit the forecast high, the stock’s price needs a -7.35% plunge from its current level, while the stock would need to tank 36.29% for it to hit the projected low.
Abbvie Inc (ABBV) estimates and forecasts
Data shows that the Abbvie Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 10.98% over the past 6 months, a -2.16% in annual growth rate that is considerably lower than the industry average of 6.50%. Year-over-year growth is forecast to reach 2.50% up from the last financial year.
Consensus estimates given by 15 financial analysts project the company’s revenue in the current quarter to hit an average of 14.26B. 14 analysts are of the opinion that Abbvie Inc’s revenue for the current quarter will be 14.62B. The company’s revenue for the corresponding quarters a year ago was 13.71B and 14.3B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 4.00%. The estimates for the next quarter sales put growth at 2.20%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -5.77%. The 2024 estimates are for Abbvie Inc earnings to decrease by -2.11%, but the outlook for the next 5-year period is at 6.26% per year.
ABBV Dividends
Abbvie Inc is expected to release its next quarterly earnings report on 2024-Oct-25. The 3.07% annual yield figure for the share gives it an annual dividend of 6.13. It is important to note, however, that the 3.07% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 4.23 per year.
Abbvie Inc (NYSE:ABBV)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.10% of Abbvie Inc shares while 73.53% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 73.60%. There are 73.53% institutions holding the Abbvie Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.6472% of the shares, roughly 170.66 million ABBV shares worth $29.27 billion.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.7124% or 136.43 million shares worth $23.4 billion as of 2024-06-30.
Among Mutual Funds, the top two as of Jun 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund . With 55.78 shares estimated at $11.12 billion under it, the former controlled 3.16% of total outstanding shares. On the other hand, Vanguard 500 Index Fund held about 2.57% of the shares, roughly 45.32 shares worth around $9.04 billion.
